Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
JPMA. the Journal of the Pakistan Medical Association|March 6, 2009
The health seeking behaviour of elderly population in a poor-urban community of Karachi, PakistanAbdullah Ladha, Romaisa Shamim Khan, Awais Amjad Malik, et al.Frontiers in Oncology|February 27, 2024
Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host diseaseYijun Cai, Amir Ali, Elan Filler, et al.Transplantation Proceedings|August 22, 2024
Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/TacrolimusKaram Ashouri, Eduardo Fernandez, Anush Ginosyan, et al.Respiratory Medicine Case Reports|October 16, 2023
Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-reviewSamvel Nazaretyan, Amir Ali, George Yaghmour, et al.Leukemia Research|April 17, 2024
Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT studyKaram Ashouri, Anush A Ginosyan, Mollee Chu, et al.Clinical Lymphoma, Myeloma & Leukemia|December 7, 2023
Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center StudyKaram Ashouri, Vinay Nittur, Anush A Ginosyan, et al.British Journal of Haematology|September 19, 2024
Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapyKaram Ashouri, Brian Hom, Anush A Ginosyan, et al.Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.Blood Advances|June 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALLTamer Othman, Gregory W Roloff, Katharine Miller, et al.Pageof 3